Patents by Inventor Rick Klausner

Rick Klausner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENRICHMENT OF MUTATED CELL FREE NUCLEIC ACIDS FOR CANCER DETECTION
    Publication number: 20230272375
    Abstract: Provided herein are methods of enriching mutated cell free nucleic acids for detection and diagnosis of cancer. Also provided are methods using a CRISPR-Cas system to target and deplete unwanted more abundant cell free nucleic acid sequences thereby enriching for less abundant sequences.
    Type: Application
    Filed: April 10, 2023
    Publication date: August 31, 2023
    Inventors: Gordon Cann, Alex Aravanis, Arash Jamshidi, Rick Klausner, Richard Rava
  • Enrichment of mutated cell free nucleic acids for cancer detection
    Patent number: 11624064
    Abstract: Provided herein are methods of enriching mutated cell free nucleic acids for detection and diagnosis of cancer. Also provided are methods using a CRISPR-Cas system to target and deplete unwanted more abundant cell free nucleic acid sequences thereby enriching for less abundant sequences.
    Type: Grant
    Filed: June 13, 2017
    Date of Patent: April 11, 2023
    Assignee: GRAIL, LLC
    Inventors: Gordon Cann, Alex Aravanis, Arash Jamshidi, Rick Klausner, Richard Rava
  • ENRICHMENT OF MUTATED CELL FREE NUCLEIC ACIDS FOR CANCER DETECTION
    Publication number: 20190161752
    Abstract: Provided herein are methods of enriching mutated cell free nucleic acids for detection and diagnosis of cancer. Also provided are methods using a CRISPR-Cas system to target and deplete unwanted more abundant cell free nucleic acid sequences thereby enriching for less abundant sequences.
    Type: Application
    Filed: June 13, 2017
    Publication date: May 30, 2019
    Inventors: Gordon Cann, Alex Aravanis, Arash Jamshidi, Rick Klausner, Richard Rava